Skip to content

Kodiak Sciences Inc KOD Accrued Expenses

Accrued Expenses at other companies

Ocular Therapeutix logo
Ocular TherapeutixOCUL
$36.49M+17.4%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$8.36M+64.1%
Vera Therapeutics logo
Vera TherapeuticsVERA
$31.24M+1,046%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$17M+408%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$10.32M+12.7%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$19M+11.8%

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Reported directly by Kodiak Sciences Inc in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's accrued expenses?
Kodiak Sciences Inc (KOD) reported accrued expenses of $26.57M in Q1 2026.
How has Kodiak Sciences Inc's accrued expenses changed year-over-year?
Kodiak Sciences Inc's accrued expenses increased by 98.5% year-over-year, from $13.39M to $26.57M.
What is the long-term trend for Kodiak Sciences Inc's accrued expenses?
Over 5 years (2020 to 2025), Kodiak Sciences Inc's accrued expenses has grown at a 0.2% compound annual growth rate (CAGR), from $20.4M to $20.61M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.